STANDARDIZATION & PHARMACOLOGICAL EVALUATION OF POLYHERBAL EXTRACT TO REPORT THE ANTICARCINOGENIC POTENTIAL

The relevance of traditional medicines and their folkloric applications for the well-being of humanity have been highlighted in the current study. To generate the polyherbal extract for the in-vitro assessment of anticancer activity, the researcher has investigated the standardization criteria for the individual plant drug and extract obtained from these herbs. According to the literature and earlier studies, all four of the herbs utilized to create polyherbal extract have the potential to cure a variety of malignancies in addition to liver carcinoma. The physiochemical and pharmacological value of each medicinal herb and the polyherbal extract of these four plant drugs (Vinca, Jackfruit, Lawsonia, and Ashwagandha) are revealed in the same research findings. Based on the results of phytochemical testing, it is evident that the majority of these phytochemicals employed include the alkaloids and steroids in n-hexane extract, which also suggests the possible anticancer effects of each drug separately. The MTT dye assay assessed the polyherbal extract’s cytotoxic impact on the Huh7 cell line. The polyherbal extract’s anticancer results are highly remarkable. For the foreseeable future, it may be possible to assess the in-vivo cancer Activity directly on the chosen animals. Some specific formulations may be created using the potent crude drug extract created by selecting these powerful anticancer plant drugs.